As of October 28, 2026, TCGX Acquisition Corp. II has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on October 19, 2026 (Form 8-K, October 19, 2026).
Sell to companies like TCGX Acquisition Corp. II? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
TCGX Acquisition Corp. II reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-10-19. Every row below is cited to the filing it comes from, and this page adds each new change as TCGX Acquisition Corp. II files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-19 | Reported | not named in the filing | 8-K, 2026-10-19 |
Selling to them or working with them? See who runs TCGX Acquisition Corp. II now and the warning signs.
Free to see. No signup.
Keep reading
More on TCGX Acquisition Corp. II and the records around it.
TCGX Acquisition Corp. II elsewhere on the record
- IPO filing Oct 2026
Companies that share a holder
- Squadron Master Fund LP also filed stake reports on 13 other companies: C4 Therapeutics, Inc. (Aug 2026), Lipocine Inc. (Aug 2026), NextCure, Inc. (Aug 2026)
- Deep Track Capital, LP also filed stake reports on 59 other companies: Alector, Inc. (Oct 2026), Frazier Life Sciences Acquisition Corp. II (Oct 2026), JATT III Acquisition Corp (Sep 2026)
- RA Capital Management, L.P. also filed stake reports on 99 other companies: Alector, Inc. (Oct 2026), Frazier Life Sciences Acquisition Corp. II (Oct 2026), Corbus Pharmaceuticals Holdings, Inc. (Sep 2026)
Watch TCGX Acquisition Corp. II
Get an email when TCGX Acquisition Corp. II files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on TCGX Acquisition Corp. II?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on TCGX Acquisition Corp. II: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TCGX Acquisition Corp. II covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
New leaders reset buying decisions — get the Full Report on TCGX Acquisition Corp. II: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at TCGX Acquisition Corp. II, with the record behind each one.
Find candidates like senior executive at TCGX Acquisition Corp. IIEvery change, in the filing's words
Reported
On October 15, 2026, in connection with the IPO, Joshua Cohen, Mark McKenna and Dr. Michael Henderson, M.D. were appointed to the board of directors of the Company (the "Board").
Tools for this story
Each opens in a new tab, filled in for TCGX Acquisition Corp. II. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.